Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Elite Pharmaceuticals Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 82.0K | 0 | −82.0K (−100.0%) |
| Value | $2.38K | $0 | −$2.38K (−100.0%) |
New holders (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (1)
Institutions that held Elite Pharmaceuticals Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Fisher Asset Management, LLC | 82,000 | $2.38K |